Maypharm Launches METOO FILL HA FILLER, Metox botulinum toxin with a 2nd generation technological advantage

METOOFILL hyaluronic acid dermal filler (CE Approved), made by Maypharm CO, LTD, overcame the limitations of traditional hyaluronic acid cross-linking technology by using patented innovative three patented technologies. METOOFILL hyaluronic acid dermal filler (CE Approved), made by Maypharm CO, LTD, overcame the limitations of traditional hyaluronic acid cross-linking technology by using patented innovative three patented technologies. 1. Microbead Monophasic Technology This patented...

METOOFILL hyaluronic acid dermal filler (CE Approved), made by Maypharm CO, LTD, overcame the limitations of traditional hyaluronic acid cross-linking technology by using patented innovative three patented technologies.

1. Microbead Monophasic Technology

This patented technology increases the gel's durability with a homogeneous structure of HA particles that provides stable volume, outstanding cohesion, and migration resistance.

2. Multi-stage Cross-linking Technology

Metoo Fill goes through a three-stage high-rate DVS cross linking process that optimizes density, provides outstanding viscoelastic properties, flexibility and an improved injectability profile while retaining the biocompatibility and physical functionality of unmodified HA.

3. Multi-degree Amphiphilic Purification

After cross-linking, Metoo Fill goes through a multi-step purification process to completely neutralize the cross-linking agent using PBS solution, resulting in a network of HA chains with a purity of over 97%, as opposed to other products in the market with a purity up to 95%.

As a result, the Metoo Fill series contains 4 lines with different gel parameters for various needs: Applying these three patented technologies, the products METOO FILL are longer-lasting, easily moldable, resulting in a very natural finish that will satisfy the client.

For further details, please contact us at maypharm@maypharm.co.kr or visit our website, https://www.may-pharm.com/

Photo - https://mma.prnewswire.com/media/2185792/METOO_FILL_HA_FILLER.jpg
Photo - https://mma.prnewswire.com/media/2185793/METOO_FILL_HA_FILLER2.jpg

View original content:https://www.prnewswire.co.uk/news-releases/maypharm-launches-metoo-fill-ha-filler-metox-botulinum-toxin-with-a-2nd-generation-technological-advantage-301900737.html